BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Juhl K, Christensen A, Rubek N, Karnov KKS, von Buchwald C, Kjaer A. Improved surgical resection of metastatic pancreatic cancer using uPAR targeted in vivo fluorescent guidance: comparison with traditional white light surgery. Oncotarget 2019;10:6308-16. [PMID: 31695839 DOI: 10.18632/oncotarget.27220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Kurbegovic S, Juhl K, Sørensen KK, Leth J, Willemoe GL, Christensen A, Adams Y, Jensen AR, von Buchwald C, Skjøth-Rasmussen J, Ploug M, Jensen KJ, Kjaer A. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts. Theranostics 2021;11:7159-74. [PMID: 34158842 DOI: 10.7150/thno.49787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 van Dam MA, Vuijk FA, Stibbe JA, Houvast RD, Luelmo SAC, Crobach S, Shahbazi Feshtali S, de Geus-Oei LF, Bonsing BA, Sier CFM, Kuppen PJK, Swijnenburg RJ, Windhorst AD, Burggraaf J, Vahrmeijer AL, Mieog JSD. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Cancers (Basel) 2021;13:6088. [PMID: 34885196 DOI: 10.3390/cancers13236088] [Reference Citation Analysis]
3 Bhandari C, Fakhry J, Eroy M, Song JJ, Samkoe K, Hasan T, Hoyt K, Obaid G. Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW. Front Oncol 2022;12:853660. [DOI: 10.3389/fonc.2022.853660] [Reference Citation Analysis]
4 Kumar AA, Buckley BJ, Ranson M. The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets. Biomolecules 2022;12:152. [DOI: 10.3390/biom12020152] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Baart VM, van Manen L, Bhairosingh SS, Vuijk FA, Iamele L, de Jonge H, Scotti C, Resnati M, Cordfunke RA, Kuppen PJK, Mazar AP, Burggraaf J, Vahrmeijer AL, Sier CFM. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors. Mol Imaging Biol 2021. [PMID: 34642899 DOI: 10.1007/s11307-021-01657-2] [Reference Citation Analysis]
6 Baart VM, van der Horst G, Deken MM, Bhairosingh SS, Schomann T, Sier VQ, van der Mark MH, Iamele L, de Jonge H, Resnati M, Mazar AP, Pelger RCM, van der Pluijm G, Kuppen PJK, Vahrmeijer AL, Sier CFM. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma. Eur J Cancer 2021;146:11-20. [PMID: 33561783 DOI: 10.1016/j.ejca.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Anani T, Rahmati S, Sultana N, David AE. MRI-traceable theranostic nanoparticles for targeted cancer treatment. Theranostics 2021;11:579-601. [PMID: 33391494 DOI: 10.7150/thno.48811] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 17.0] [Reference Citation Analysis]
8 Skjøth-Rasmussen J, Azam A, Larsen CC, Scheie D, Juhl K, Kjaer A. A new uPAR-targeting fluorescent probe for optical guided intracranial surgery in resection of a meningioma-a case report. Acta Neurochir (Wien) 2022;164:267-71. [PMID: 34748074 DOI: 10.1007/s00701-021-05051-3] [Reference Citation Analysis]
9 Baart VM, Houvast RD, de Geus-Oei LF, Quax PHA, Kuppen PJK, Vahrmeijer AL, Sier CFM. Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer. EJNMMI Res 2020;10:87. [PMID: 32725278 DOI: 10.1186/s13550-020-00673-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Simón M, Jørgensen JT, Melander F, Andresen TL, Christensen A, Kjaer A. Photothermal Therapy as Adjuvant to Surgery in an Orthotopic Mouse Model of Human Fibrosarcoma. Cancers (Basel) 2021;13:5820. [PMID: 34830974 DOI: 10.3390/cancers13225820] [Reference Citation Analysis]
11 Leth JM, Ploug M. Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention. Front Cell Dev Biol 2021;9:732015. [PMID: 34490277 DOI: 10.3389/fcell.2021.732015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Simón M, Jørgensen JT, Juhl K, Kjaer A. The use of a uPAR-targeted probe for photothermal cancer therapy prolongs survival in a xenograft mouse model of glioblastoma. Oncotarget 2021;12:1366-76. [PMID: 34262647 DOI: 10.18632/oncotarget.28013] [Reference Citation Analysis]